Gene Query: OIP5

Dataset Description Geneva Score
scRNASeq analysis of cycling cardiomyocytes 10.19
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 10.14
RNAseq Study in CC-671 Treated Cal-51 Cells 8.84
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.11
SUV420H2 knockdown in PANC-1 7.81
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 7.17
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 7.08
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.82
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.11
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.98
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 5.77
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.63
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.02
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.75
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.75
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.54
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.51
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.35
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.12
The Human Testis Cell Atlas via Single-cell RNA-seq 4.12
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 3.95
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 3.93
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 3.93
Neonatal and adult human testis defined at the single-cell level 3.92
LIN28A Over-expression RNAseq 3.91
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.88
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.86
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.84
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.84
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.84
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.82
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.61
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.6
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.56
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.39
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.32
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 3.29
Cajal bodies are linked to genome conformation 3.23
Cajal bodies are linked to genome conformation [RNA-Seq] 3.23
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.23
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.19
Effect of CHKA knockdown on C4-2 cell transcriptome 3.19
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.17
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.14
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 3.13
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.12
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.12
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.08
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 3.06
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 3.01
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.98
The regulartory role of ZCCHC24 in splicing machinery 2.91
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 2.85
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 2.85
ETV7 and interferon response 2.84
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.84
Gene expression in PANC1 cells treated with Rakicidin 2.84
Identification of transcription start sites for human A549 cell line using ReCappable-seq 2.78
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 2.76
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.73
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.71
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.69
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.66
Genome-wide transcriptional response to random aneuploidy in human cells 2.64
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 2.62
Rorc disruption in human FG pancreatic cancer cells 2.61
Altering cancer transcriptomes using epigenomic inhibitors 2.59
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 2.59
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 2.56
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.54
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.46
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 2.43
Identification of global regulators of T-helper cell lineage specification 2.42
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.42
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.41
Accurate annotation of human protein-coding small open reading frames 2.37
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.34
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.34
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 2.34
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 2.33
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.33
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.33
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.33
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.28
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 2.25
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 2.23
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 2.22
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 2.21
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.19
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.18
Transcriptome sequencing of K-562 cells 2.16
The landscape of alternative splicing in aggressive prostate cancers 2.15
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 2.14
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.14
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.12
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.12
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.1
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.07
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.06
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.06
RNAseq analysis of ESRP regulated splicing events in prostate cancer 2.05
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.04
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 2.02
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.01
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.01
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.01
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 2.01
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.0
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 1.98
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.97
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 1.97
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.96
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 1.94
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.92
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 1.91
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.91
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.9
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.9
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.9
Identification of HOXB13 target genes responsive to BET inhibitors 1.89
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.88
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 1.88
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.87
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 1.85
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 1.84
Role for citron kinase in prostate cancer growth 1.84
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.84
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.82
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 1.81
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 1.8
RNAseq of T-ALL upon long non coding rna purturbation 1.8
Transcriptome analysis of H9 hESC derived cerebral organoids 1.8
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.8
Exploring ILF2 regulatory genes by next-generation sequencing 1.79
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.79
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 1.78
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.77
Global analysis of enhancer targets: Mosaic-seq 1.76
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 1.75
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.75
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 1.75
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.74
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.74
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.74
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 1.74
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.74
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.74
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.74
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.73
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.72
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.71
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.69
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.68
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 1.67
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.67
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.66
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 1.66
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.64
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 1.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 1.64
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 1.63
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.62
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.62
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 1.62
Paxillin regulates genomic networks in prostate cancer [LNCaP] 1.6
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 1.6
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 1.6
Tracking of dCas9-methyltransferase footprints 1.59
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 1.59
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.57
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.56
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.56
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 1.56
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.52
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.52
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.5
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 1.49
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.47
Single-cell analysis of adult human ovary using 10X genomics 1.47
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.47
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 1.46
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.46
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.46
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.46
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.45
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.44
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.44
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.43
Characterization of parental and rociletinib-resistant derived H1975 cell lines 1.42
TCF7L1 knockdown in pancreatic cancer 1.41
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 1.41
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.39
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 1.39
RNA-seq analysis to identify the genes regulated by p53-SET interplay 1.38
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.37
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.37
Hijacking of stress response machinery by oncogenes in acute leukaemia 1.36
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 1.36
Transcriptional responses of human insulinoma cells to acute cytokine exposure 1.36
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.35
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.35
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 1.35
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 1.35
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 1.34
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 1.34
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.34
Oncogenic roles of ARID5B in T-ALL 1.34
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 1.34
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 1.32
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.31
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.31
Transcriptome analysis of U87 cells upon LINC00152 knockdown 1.31
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.31
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.3
The conserved transcriptional landscapes in human spermatogenesis 1.3
Role of FGFR1 in neuronal devlopment 1.3
Genome-wide discovery of human splicing branchpoints 1.29
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.29
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.29
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.29
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.28
DART-seq: an antibody-free method for global m6A detection 1.27
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.26
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.26
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.24
Differentially expressed vascular development genes for iPSC-ECs from CDI 1.24
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.24
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 1.24
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.24
MYCi361 regulates MYC target genes 1.23
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 1.23
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.22
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.22
RNA polymerase in pre-B-ALL cell lines 1.22
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 1.22
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.21
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.21
Control of prostate tumour growth by the long non-coding RNA GHSROS 1.21
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 1.21
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 1.21
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.21
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.2
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.2
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.2
IDH3a KO RNA-seq 1.2
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.2
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 1.19
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 1.19
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.18
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 1.18
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.18
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.18
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.18
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.17
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 1.17
Gene expression analysis of the impact of TDP-43 knockout in human cells. 1.17
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 1.17
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 1.17
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.16
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.15
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.15
LNCaP treated with iBET 1.15
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 1.15
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.15
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 1.14
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.11
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.11
Impact of dieldrin on transcription in Jurkat T cells 1.11
K562 polyA RNA-Seq 1.11
Real-time observation of light-controlled transcription in living cells 1.11
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.11
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.1
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 1.1
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 1.09
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.09
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.08
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 1.07
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.07
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.07
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 1.07
Genome-wide chromatin analysis of Ewing sarcoma 1.07
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.07
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.06
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 1.05
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 1.05
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 1.04
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 1.04
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.04
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.04
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.03
Gene expression changes after LOC550643 silencing 1.03
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 1.02
Regulation of protein translation during mitosis 1.01
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.01
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.01
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.0
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 0.99
UBC9 knockdown in bladder cancer T24 cell lines 0.99
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.98
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.98
The cohesin complex prevents Myc-induced replication stress 0.98
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.97
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.97
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.94
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.92
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 0.92
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.91
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.9
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.89
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.89
Effect of ILF3 on translation during homeostasis and the antiviral response 0.88
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.87
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.87
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.87
Paxillin regulates genomic networks in prostate cancer [PC3] 0.86
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 0.86
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 0.86
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.85
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.84
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 0.84
Bone marrow derived human B cells [normal proB] 0.83
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.82
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.82
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 0.82
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.82
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.81
Transcriptome analysis of BAP1 knockout and restoration 0.81
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.81
Gene expression changes due to PARP knockdown in human cells 0.8
Human Treg NaCl stimulation 0.79
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.78
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 0.78
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.76
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.75
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 0.75
RNA-sequencing in immortalized human mammary epithelial cells 0.75
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.75
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.74
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.74
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.73
U2AF1 mutations alter splice site recognition in hematological malignancies 0.72
RNA-seq analysis of differentiating human erythroblasts 0.71
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.7
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.7
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.69
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.68
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.68
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.68
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.68
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 0.68
Transcriptome-wide identification of CELF2 functional targets in T cells 0.68
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.67
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.67
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.66
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 0.65
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.65
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.65
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.65
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.65
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.64
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.64
RNA-seq of tumor cells following angiopellosis extravasation 0.64
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.64
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.64
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.63
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.63
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.63
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.62
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.62
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 0.62
The Genetic Landscape of Diamond-Blackfan Anemia 0.61
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.61
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 0.6
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.6
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.59
Human Treg IL-12 stimulation 0.59
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.57
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.57
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.56
RNA-seq analyisis of PUM2 knockout cells 0.55
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.54
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.54
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.54
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 0.54
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 0.54
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 0.53
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 0.53
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.53
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.52
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.52
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.52
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 0.51
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.5
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.49
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.49
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.48
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 0.47
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.45
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.45
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.45
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.44
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.44
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.44
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 0.43
Impact on erythroid progenitor type on erythroid differntiation 0.43
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.43
Functional significance of the HIV-1 Tat signature amino acid residues 0.43
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.42
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.42
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.42
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.42
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.42
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.42
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.41
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.4
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.4
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.39
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 0.38
Effect of PRDM11 depletion in U2932 cells 0.38
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.37
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.34
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.34
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.32
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.32
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.32
p53 activity results in DNA replication fork processivity 0.31
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.3
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.3
Transcriptome-wide modulation of splicing by the exon junction complex 0.29
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.28
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.28
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.28
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.27
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.26
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.26
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.25
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.25
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.23
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.23
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.23
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.23
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.23
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.23
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.23
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.22
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.2
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.2
Specific molecular signatures underlie response to decitabine in CMML 0.2
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.2
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.19
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.19
RNA seq with AML (NB4) cells upon FTO inhibition 0.17
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.16
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.15
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.15
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.15
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.14
hnRNP C is a key regulator of protein synthesis in mitosis 0.14
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.13
Transcriptional landscape changes during human embryonic stem cell derivation 0.12
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.12
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.12
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.1
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.1
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.1
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.09
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.09
HEK293 TFAM Knockout Expression Study 0.09
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.08
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.08
iPSC-Derived Cholangiocytes 0.08
RNA seq analysis of human Fetal and adult derived Enterospheres 0.08
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.07
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.05
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.05
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.05
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.05
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.05
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.04
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.04
Genome-wide analysis of the Integrator complex 0.03
Genome-wide analysis of the Integrator complex (HTS) 0.03
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.03
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.03
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.02
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.02
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.01
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.01
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.01
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.01
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation